SCHEMBL5953079

SCHEMBL5953079

CCCCB(O)OC(C)(C)C(C)(C)O

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 1/20 0.41
PCSK9 Q8NBP7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL661999 0.94 ANPEP (0.34) ANPEP
SCHEMBL17891917 0.92 ANPEP (0.33) ANPEP
SCHEMBL9903702 0.82
SCHEMBL1300947 0.82
SCHEMBL290668 0.77 ALDH1A1 (0.31)
SCHEMBL3709629 0.74
SCHEMBL17652427 0.72 FAAH (0.38)
SCHEMBL10624549 0.71
SCHEMBL18074209 0.71
SCHEMBL5838629 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720169-A1 POLYMER BLENDS COMPRISING POLYETHYLENE (METH) ACRYLIC ACID IONOMERS AND BORONIC ESTER CROSSLINKERS Dow Global Technologies LLC (US) 2026-04-08 EP claimed
WO-2024250153-A1 POLYMER BLENDS COMPRISING POLYETHYLENE (METH) ACRYLIC ACID IONOMERS AND BORONIC ESTER CROSSLINKERS DOW GLOBAL TECHNOLOGIES LLC (US) 2024-12-12 WO claimed
US-20260135164-A1 LITHIUM SECONDARY BATTERIES CAPABLE OF SELF-POISONING PROLOGIUM TECHNOLOGY CO., LTD. (TW) 2026-05-14 US disclosed
EP-4720169-A1 POLYMER BLENDS COMPRISING POLYETHYLENE (METH) ACRYLIC ACID IONOMERS AND BORONIC ESTER CROSSLINKERS Dow Global Technologies LLC (US) 2026-04-08 EP disclosed
EP-4668366-A1 LITHIUM SECONDARY BATTERY CAPABLE OF SELF-POISONING Prologium Technology Co., Ltd. (TW) 2025-12-24 EP disclosed
WO-2024250153-A1 POLYMER BLENDS COMPRISING POLYETHYLENE (METH) ACRYLIC ACID IONOMERS AND BORONIC ESTER CROSSLINKERS DOW GLOBAL TECHNOLOGIES LLC (US) 2024-12-12 WO disclosed
US-20180312473-A1 PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2018-11-01 US disclosed
US-7038070-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2006-05-02 US disclosed
US-6963017-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2005-11-08 US disclosed
EP-0968158-B1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM BASELL POLYOLEFINE GMBH (DE) 2005-08-10 EP disclosed
US-20050033076-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2005-02-10 US disclosed
US-20030009046-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2003-01-09 US disclosed
US-4701545-A REACTING STERICALLY HINDERED BASE WITH MIXTURE OF DIHALOALKANE AND TRIALKYL BORATE WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 1987-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260135164-A1 LITHIUM SECONDARY BATTERIES CAPABLE OF SELF-POISONING L3MBTL3, HAO2, LDHB ANPEP 4518/4885PCSK9 4075/4885
US-20180312473-A1 PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS ROS1, NOX4, NOX5 ANPEP 3758/4885PCSK9 2886/4885
US-20050033076-A1 Preparation of preparing substituted indanones CYP1A2, CYP2J2, IDH3A ANPEP 3546/4885PCSK9 3742/4885
US-20030009046-A1 Preparation of preparing substituted indanones CYP1A2, CYP1B1, CYP1A1 ANPEP 3741/4885PCSK9 3869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.